1 Pantoni L. Cerebral small vessel disease:f rom

pathogenesis and clinical characteristics to therapeutic

challenges[J]. Lancet Neurol, 2010, 9:689-701.

2 Wa rdlaw JM, Smi th EE, Bies sels GJ, e t a l .

Neuroimaging standards for research into small

vessel disease and its contribution to ageing and

neurodegeneration[J]. Lancet Neurol, 2013, 12:822-838.

3 Vernooij MW, van der Lugt A, Ikram MA, et al.

Prevalence and risk factors of cerebral microbleeds:the

Rotterdam Scan Study[J]. Neurology, 2008, 70:1208-1214.

4 Schulz UG, Gruter BE, Briley D, et al. Leukoaraiosis

and increased cerebral susceptibility to ischemia:lack

of confounding by carotid disease[J]. J Am Heart

Assoc, 2013, 2:e000261.

5 Kim TH, Choi JW, Roh HG, et al. Atherosclerotic

arterial wall change of non-stenotic intracracranial

arteries on high-resolution mri at 3. 0T:Correlation

with cerebrovascular risk factors and white matter

hyperintensity[J]. Clin Neurol Neurosurg, 2014, 126:1-6.

6 Brisset M, Boutouyrie P, Pico F, et al. Large-vessel

cor relates of cerebral small-vessel disease[J].Neurology, 2013, 80:662-669.

7 Viswanathan A, Rocca WA, Tzourio C. Vascular

risk factors and dementia:how to move forward?[J].

Neurology, 2009, 72:368-374.

8 Carare RO, Hawkes CA, Jeffrey M, et al. Review:

Cerebral amyloid angiopathy, prion angiopathy,

cadasil and the spectrum of protein elimination failure

angiopathies (pefa) in neurodegenerative disease with

a focus on therapy[J]. Neuropathol Appl Neurobiol,

2013, 39:593-611.

9 Bath PM, Wardlaw JM. Pharmacological treatment

and prevention of cerebral small vessel disease:a

review of potential interventions[J]. Int J Stroke,

2015, 10:469-478.